Nasdaq: BBIO

BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker BBIO. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
BBIO
Exchange
Nasdaq
SEC CIK
1743881
Official filings
SEC EDGAR

Research BBIO

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is BridgeBio Pharma, Inc.'s stock ticker?

BridgeBio Pharma, Inc. trades under the ticker symbol BBIO on Nasdaq. Its SEC Central Index Key (CIK) is 1743881.

Where can I read BridgeBio Pharma, Inc.'s SEC filings?

The BBIO SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports BridgeBio Pharma, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze BBIO's financial statements?

The BBIO Financials page shows BridgeBio Pharma, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does BBIO compare with its peers and the market?

The BBIO Peer Comparison page lines BridgeBio Pharma, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.